Beijing, China, August 31, 2023 – Hangzhou Jianjia Robot Co., Ltd. has received approval from the National Medical Products Administration (NMPA) for its Arthrobot Hip and Knee Multi-Application Surgical Robot (Product Name: Joint Replacement Surgery Navigation and Positioning System).
Arthrobot Joint Replacement Surgery Navigation and Positioning System
In April 2022, Jianjia Robot obtained the NMPA's first registration certificate for a joint surgery robot, marking a significant milestone. The approval of the Arthrobot for hip and knee applications signifies a historic breakthrough for China's domestically manufactured surgical robots. It further breaks the monopoly of imported brands, accelerates the enhancement of China's surgical robot clinical capabilities, and benefits a greater number of Chinese patients. About Jianjia Robot
Hangzhou Jianjia Medical Technology Co., Ltd. is a high-tech enterprise focusing on the R&D, production and sales of surgical robots and related products. The company's main product, the ARTHROBOT hip replacement surgery robot became the first domestic hip replacement surgery robot to obtain a Class III medical device registration certificate in April 2022. ARTHROBOT series products can be used in hip and knee replacement surgery at the same time, breaking the long-term monopoly of imported joint replacement surgery robots in this field.
Comments